CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hepatitis b cure hope: new study targets virus clearance in 10,000 patients
⭐️ CURE ⭐️ Not yet recruitingThis study looks at whether a medicine called peginterferon alfa, alone or with other antivirals, can clear the hepatitis B virus from the body in people who have already been treated with interferon. The goal is to achieve a functional cure, meaning the virus is undetectable and…
Matched conditions: CHRONIC HEPATITIS B
Sponsor: xieqing • Aim: ⭐️ CURE ⭐️
Last updated May 26, 2026 02:03 UTC
-
Could this combo cure hepatitis b in kids?
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether giving two medicines together can cure chronic hepatitis B in children aged 3 to 6 years. The goal is to completely clear the virus from the body for at least 6 months after treatment ends. Sixty children will be randomly assigned to receive either one dr…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE4 • Sponsor: Qing-Lei Zeng • Aim: ⭐️ CURE ⭐️
Last updated May 19, 2026 12:01 UTC
-
Mass hepatitis b screening aims to prevent liver cancer in thailand
Disease control Not yet recruitingThis study will screen nearly 240,000 adults in Phichit, Thailand, who were born before 1992 and may have undiagnosed hepatitis B. Those who test positive will be linked to care and offered a daily antiviral pill to control the virus and prevent liver damage. The goal is to find …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE4 • Sponsor: The Task Force for Global Health • Aim: Disease control
Last updated May 26, 2026 02:11 UTC
-
AI agent aims to close the hepatitis b treatment gap
Disease control Not yet recruitingThis study tests whether an AI-powered smartphone tool can help more people with chronic hepatitis B start antiviral treatment. Many people are diagnosed but never begin therapy due to fear, lack of awareness, or poor communication with doctors. The study will enroll 2000 adults …
Matched conditions: CHRONIC HEPATITIS B
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Can a drug combo cure hepatitis b in toddlers? new study aims to find out
Disease control Not yet recruitingThis study tests whether giving two medicines—entecavir followed by pegylated interferon—can achieve a 'functional cure' for chronic hepatitis B in children aged 3 to 6 years. A functional cure means the virus is suppressed and no longer active, even after treatment stops. The tr…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE4 • Sponsor: Qing-Lei Zeng • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug ACT500 targets dual liver disease in early trial
Disease control Not yet recruitingThis early-stage study tests a new oral drug called ACT500 in 24 adults who have both fatty liver disease and chronic hepatitis B. The main goal is to check the drug's safety and how the body processes it. Participants will take the drug once daily for a short time, and researche…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New vaccine aims to tame chronic hepatitis b
Disease control Not yet recruitingThis study tests a new vaccine designed to help the immune system control or possibly cure chronic hepatitis B. About 40 adults with chronic hepatitis B will receive the vaccine to see if it is safe and can lower the virus level in their blood. The goal is to reduce the need for …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1, PHASE2 • Sponsor: Vaxine Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New injection tested in patients with liver issues
Knowledge-focused Not yet recruitingThis early-stage study looks at how the body handles a new injection called AHB-137 and whether it is safe. It includes 32 adults with chronic hepatitis B who have either mild to moderate liver problems or normal liver function. The goal is to measure drug levels in the blood and…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 02:09 UTC